wherein no more than one of X 10 , X 12 , X 13 , X 14 , X 16 , X 17 , X 19 , X 20 , X 21 , X 23 , X 24 , X 26 , X 27 , X 28 , X 29 , X 30 , X 31 , X 32 , X 33 , X 34 , X 35 , X 36 , X 37 , X 38 , X 39 , and X 40 may be a substituent that contains a fatty acid
Key biochemical markers, such as alanine aminotransferase (ALT), total bilirubin (TBIL), aspartate aminotransferase (AST), and albumin (ALB), are widely used to reflect liver function

Tirzepatide may be appropriate for individuals who: Have a BMI of 30 or higher (obesity), or 27 or higher with a weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia Have not achieved adequate results through diet and exercise alone Have pre-diabetes and need improved blood sugar control and weight management Are committed to ongoing medical supervision and lifestyle support throughout treatment Tirzepatide is not appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Are pregnant or planning to become pregnant Have a known hypersensitivity reaction to tirzepatide or its ingredients Have a history of confirmed pancreatitis (discuss with provider) If you are considering tirzepatide and want a comprehensive assessment of whether it is appropriate for your specific health profile, TRT Nations Medical Weight Loss Assessment is a clinically guided starting point designed to help patients and providers align on the right treatment approach

If its been left at room temperature for too long, it may not be effective anymore